{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T00:03:46Z","timestamp":1788393826997,"version":"build-2803163510"},"reference-count":245,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100012576","name":"Guangdong Basic and Applied Basic Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012576","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cellular Signalling"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.cellsig.2026.112689","type":"journal-article","created":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T23:23:53Z","timestamp":1782170633000},"page":"112689","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Neuroinflammation-centered pathophysiology and therapeutic strategy design in Alzheimer's disease: Cutting-edge developments"],"prefix":"10.1016","volume":"146","author":[{"given":"Deyu","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhezuo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenhui","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinhang","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunwei","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guran","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10284","key":"10.1016\/j.cellsig.2026.112689_bb0005","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1016\/S0140-6736(20)32205-4","article-title":"Alzheimer\u2019s disease","volume":"397","author":"Scheltens","year":"2021","journal-title":"Lancet (London, England)"},{"issue":"7","key":"10.1016\/j.cellsig.2026.112689_bb0010","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.1002\/alz.12901","article-title":"The worldwide costs of dementia in 2019","volume":"19","author":"Wimo","year":"2023","journal-title":"Alzheimers Dement."},{"issue":"3","key":"10.1016\/j.cellsig.2026.112689_bb0015","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/s41588-018-0311-9","article-title":"Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer\u2019s disease risk","volume":"51","author":"Jansen","year":"2019","journal-title":"Nat. Genet."},{"issue":"4","key":"10.1016\/j.cellsig.2026.112689_bb0020","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/s41588-022-01024-z","article-title":"New insights into the genetic etiology of Alzheimer\u2019s disease and related dementias","volume":"54","author":"Bellenguez","year":"2022","journal-title":"Nat. Genet."},{"issue":"24","key":"10.1016\/j.cellsig.2026.112689_bb0025","doi-asserted-by":"crossref","DOI":"10.3390\/molecules25245789","article-title":"Comprehensive review on Alzheimer\u2019s disease: causes and treatment","volume":"25","author":"Breijyeh","year":"2020","journal-title":"Molecules (Basel, Switzerland)"},{"issue":"4","key":"10.1016\/j.cellsig.2026.112689_bb0030","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1002\/alz.13016","article-title":"2023 Alzheimer's disease facts and figures","volume":"19","year":"2023","journal-title":"Alzheimers Dement."},{"issue":"20","key":"10.1016\/j.cellsig.2026.112689_bb0035","doi-asserted-by":"crossref","first-page":"4260","DOI":"10.1016\/j.cell.2023.08.021","article-title":"Alzheimer\u2019s disease: from immunotherapy to immunoprevention","volume":"186","author":"Jucker","year":"2023","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.cellsig.2026.112689_bb0040","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/S1474-4422(20)30440-3","article-title":"New insights into atypical Alzheimer\u2019s disease in the era of biomarkers","volume":"20","author":"Graff-Radford","year":"2021","journal-title":"Lancet Neurol."},{"issue":"7","key":"10.1016\/j.cellsig.2026.112689_bb0045","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24076518","article-title":"Inflammatory processes in Alzheimer\u2019s disease-Pathomechanism, diagnosis and treatment: a review","volume":"24","author":"Twarowski","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112689_bb0050","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24010107","article-title":"Pathogenesis of Alzheimer\u2019s disease","volume":"24","author":"Rostagno","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"21","key":"10.1016\/j.cellsig.2026.112689_bb0055","doi-asserted-by":"crossref","DOI":"10.3390\/nu14214564","article-title":"Diet in the prevention of Alzheimer\u2019s disease: current knowledge and future research requirements","volume":"14","author":"Stefaniak","year":"2022","journal-title":"Nutrients"},{"issue":"1","key":"10.1016\/j.cellsig.2026.112689_bb0060","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/S1474-4422(20)30412-9","article-title":"APOE and Alzheimer\u2019s disease: advances in genetics, pathophysiology, and therapeutic approaches","volume":"20","author":"Serrano-Pozo","year":"2021","journal-title":"Lancet Neurol."},{"issue":"7","key":"10.1016\/j.cellsig.2026.112689_bb0065","article-title":"Alzheimer\u2019s disease \u2013 diagnosis and treatment","volume":"141","author":"Knapskog","year":"2021","journal-title":"Tidsskrift for den Norske laegeforening\u202f: tidsskrift for praktisk medicin, ny raekke"},{"issue":"6","key":"10.1016\/j.cellsig.2026.112689_bb0070","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.24272\/j.issn.2095-8137.2022.289","article-title":"Animal models of Alzheimer\u2019s disease: applications, evaluation, and perspectives","volume":"43","author":"Chen","year":"2022","journal-title":"Zool. Res."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112689_bb0075","doi-asserted-by":"crossref","first-page":"2","DOI":"10.2174\/1874609814666210302085232","article-title":"Alzheimer\u2019s disease: pathogenesis and therapeutic interventions","volume":"15","author":"Ogbodo","year":"2022","journal-title":"Curr. Aging Sci."},{"issue":"8","key":"10.1016\/j.cellsig.2026.112689_bb0080","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/S1474-4422(22)00168-5","article-title":"Tau protein biomarkers in Alzheimer\u2019s disease: towards implementation in clinical practice and trials","volume":"21","author":"Ossenkoppele","year":"2022","journal-title":"Lancet Neurol."},{"issue":"2","key":"10.1016\/j.cellsig.2026.112689_bb0085","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24021059","article-title":"Alzheimer\u2019s disease-biochemical and psychological background for diagnosis and treatment","volume":"24","author":"Beata","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"9","key":"10.1016\/j.cellsig.2026.112689_bb0090","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1038\/s41591-023-02505-2","article-title":"Emerging diagnostics and therapeutics for Alzheimer disease","volume":"29","author":"Self","year":"2023","journal-title":"Nat. Med."},{"key":"10.1016\/j.cellsig.2026.112689_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2021.119129","article-title":"A review on advances of treatment modalities for Alzheimer\u2019s disease","volume":"276","author":"Se Thoe","year":"2021","journal-title":"Life Sci."},{"issue":"6","key":"10.1016\/j.cellsig.2026.112689_bb0100","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.24272\/j.issn.2095-8137.2023.294","article-title":"Targeting autophagy in Alzheimer\u2019s disease: animal models and mechanisms","volume":"44","author":"Zhang","year":"2023","journal-title":"Zool. Res."},{"key":"10.1016\/j.cellsig.2026.112689_bb0105","article-title":"Microglia in the Neuroinflammatory pathogenesis of Alzheimer\u2019s disease and related therapeutic targets","volume":"13","author":"Cai","year":"2022","journal-title":"Front. Immunol."},{"issue":"7","key":"10.1016\/j.cellsig.2026.112689_bb0110","doi-asserted-by":"crossref","first-page":"5629","DOI":"10.1007\/s11033-021-06512-9","article-title":"Recent advances on drug development and emerging therapeutic agents for Alzheimer\u2019s disease","volume":"48","author":"Athar","year":"2021","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.cellsig.2026.112689_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2024.102599","article-title":"An overview of the genes and biomarkers in Alzheimer\u2019s disease","volume":"104","author":"Krishnamurthy","year":"2025","journal-title":"Ageing Res. Rev."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112689_bb0120","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/s13287-024-03737-w","article-title":"Promoting Alzheimer\u2019s disease research and therapy with stem cell technology","volume":"15","author":"Cao","year":"2024","journal-title":"Stem Cell Res. Ther."},{"issue":"4","key":"10.1016\/j.cellsig.2026.112689_bb0125","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.3233\/JAD-230418","article-title":"Diet\u2019s role in modifying risk of Alzheimer\u2019s disease: history and present understanding","volume":"96","author":"Grant","year":"2023","journal-title":"J. Alzheimer\u2019s Dis."},{"issue":"2","key":"10.1016\/j.cellsig.2026.112689_bb0130","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1007\/s12015-021-10254-3","article-title":"Human iPSC-derived neural models for studying Alzheimer\u2019s disease: from neural stem cells to cerebral organoids","volume":"18","author":"Barak","year":"2022","journal-title":"Stem Cell Rev. Rep."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112689_bb0135","doi-asserted-by":"crossref","first-page":"249","DOI":"10.14283\/jpad.2023.82","article-title":"Oral health as a risk factor for Alzheimer disease","volume":"11","author":"Pruntel","year":"2024","journal-title":"J. Prev Alzheimers Dis."},{"key":"10.1016\/j.cellsig.2026.112689_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2024.105291","article-title":"Alzheimer\u2019s disease biomarkers and the tyranny of treatment","volume":"108","author":"Karlawish","year":"2024","journal-title":"EBioMedicine"},{"key":"10.1016\/j.cellsig.2026.112689_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2024.102309","article-title":"Mechanistic insights and emerging therapeutic stratagems for Alzheimer\u2019s disease","volume":"97","author":"Rajendran","year":"2024","journal-title":"Ageing Res. Rev."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112689_bb0150","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/s12276-023-01146-2","article-title":"Current understanding of the Alzheimer\u2019s disease-associated microbiome and therapeutic strategies","volume":"56","author":"Seo","year":"2024","journal-title":"Exp. Mol. Med."},{"issue":"7","key":"10.1016\/j.cellsig.2026.112689_bb0155","doi-asserted-by":"crossref","DOI":"10.3390\/biom14070833","article-title":"Targeting microglia in Alzheimer\u2019s disease: pathogenesis and potential therapeutic strategies","volume":"14","author":"Sun","year":"2024","journal-title":"Biomolecules"},{"issue":"13","key":"10.1016\/j.cellsig.2026.112689_bb0160","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25137084","article-title":"Resistance exercise training as a new trend in Alzheimer\u2019s disease research: from molecular mechanisms to prevention","volume":"25","author":"Sep\u00falveda-Lara","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.cellsig.2026.112689_bb0165","doi-asserted-by":"crossref","DOI":"10.1111\/acel.14137","article-title":"Multi-proteomic analyses of 5xFAD mice reveal new molecular signatures of early-stage Alzheimer\u2019s disease","volume":"23","author":"Lee","year":"2024","journal-title":"Aging Cell"},{"key":"10.1016\/j.cellsig.2026.112689_bb0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2024.102478","article-title":"Glymphotherapeutics for Alzheimer\u2019s disease: time to move the needle","volume":"101","author":"MohanaSundaram","year":"2024","journal-title":"Ageing Res. Rev."},{"issue":"189","key":"10.1016\/j.cellsig.2026.112689_bb0175","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.24976\/Discov.Med.202436189.179","article-title":"Role of apolipoprotein E in Alzheimer\u2019s disease pathogenesis, prognosis and treatment","volume":"36","author":"Reiss","year":"2024","journal-title":"Discov. Med."},{"issue":"2","key":"10.1016\/j.cellsig.2026.112689_bb0180","doi-asserted-by":"crossref","first-page":"439","DOI":"10.3233\/JAD-230454","article-title":"Toward prevention and reduction of Alzheimer\u2019s disease","volume":"96","author":"Gonz\u00e1lez-Madrid","year":"2023","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"10.1016\/j.cellsig.2026.112689_bb0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115382","article-title":"Small-molecule theranostics in Alzheimer\u2019s disease","volume":"255","author":"Sarabia-Vallejo","year":"2023","journal-title":"Eur. J. Med. Chem."},{"issue":"3","key":"10.1016\/j.cellsig.2026.112689_bb0190","doi-asserted-by":"crossref","first-page":"166","DOI":"10.2174\/0115672050320921240627050736","article-title":"A look at the etiology of Alzheimer\u2019s disease based on the brain ischemia model","volume":"21","author":"Pluta","year":"2024","journal-title":"Curr. Alzheimer Res."},{"issue":"2","key":"10.1016\/j.cellsig.2026.112689_bb0195","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.mcna.2024.10.003","article-title":"Alzheimer\u2019s disease diagnosis and Management in the age of amyloid monoclonal antibodies","volume":"109","author":"Hales","year":"2025","journal-title":"Med. Clin. North Am."},{"key":"10.1016\/j.cellsig.2026.112689_bb0200","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.106119","article-title":"A role for RNA knots in Alzheimer\u2019s disease","volume":"14","author":"Galli","year":"2025","journal-title":"eLife"},{"key":"10.1016\/j.cellsig.2026.112689_bb0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2025.177520","article-title":"Exploring Alzheimer\u2019s disease treatment: established therapies and novel strategies for future care","volume":"998","author":"Soni","year":"2025","journal-title":"Eur. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112689_bb0210","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1007\/s10571-024-01514-0","article-title":"Molecular and cellular foundations of aging of the brain: anti-aging strategies in Alzheimer\u2019s disease","volume":"44","author":"Dziewa","year":"2024","journal-title":"Cell. Mol. Neurobiol."},{"issue":"4","key":"10.1016\/j.cellsig.2026.112689_bb0215","doi-asserted-by":"crossref","first-page":"5507","DOI":"10.1007\/s11357-025-01661-2","article-title":"\u201cDoctored: fraud, arrogance, and tragedy in the quest to cure Alzheimer\u2019s\u201d: an important new book with direct relevance to GeroScience","volume":"47","author":"Szabo","year":"2025","journal-title":"GeroScience"},{"issue":"2","key":"10.1016\/j.cellsig.2026.112689_bb0220","doi-asserted-by":"crossref","DOI":"10.1002\/alz.14481","article-title":"Lactylation of tau protein in human Alzheimer\u2019s disease brains","volume":"21","author":"Zhang","year":"2025","journal-title":"Alzheimers Dement."},{"issue":"2","key":"10.1016\/j.cellsig.2026.112689_bb0225","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1038\/s41591-024-03400-0","article-title":"Phospho-tau protein serine-262 and serine-356 as biomarkers of pre-tangle soluble tau protein assemblies in Alzheimer\u2019s disease","volume":"31","author":"Islam","year":"2025","journal-title":"Nat. Med."},{"issue":"8078","key":"10.1016\/j.cellsig.2026.112689_bb0230","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1038\/s41586-025-09244-z","article-title":"How short peptides disassemble tau protein fibrils in Alzheimer\u2019s disease","volume":"644","author":"Hou","year":"2025","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.cellsig.2026.112689_bb0235","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1038\/s41591-025-03617-7","article-title":"Plasma MTBR-tau protein243 biomarker identifies tau protein tangle pathology in Alzheimer\u2019s disease","volume":"31","author":"Horie","year":"2025","journal-title":"Nat. Med."},{"issue":"12","key":"10.1016\/j.cellsig.2026.112689_bb0240","doi-asserted-by":"crossref","first-page":"4303","DOI":"10.1016\/j.ymthe.2024.11.003","article-title":"AAVrh.10 delivery of novel APOE2-Christchurch variant suppresses amyloid and tau protein pathology in Alzheimer\u2019s disease mice","volume":"32","author":"G\u00fcnaydin","year":"2024","journal-title":"Mol. Ther."},{"key":"10.1016\/j.cellsig.2026.112689_bb0245","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.freeradbiomed.2024.09.021","article-title":"The effect of tau protein K677 lactylation on ferritinophagy and ferroptosis in Alzheimer\u2019s disease","volume":"224","author":"An","year":"2024","journal-title":"Free Radic. Biol. Med."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112689_bb0250","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s40035-025-00465-w","article-title":"Second-generation anti-amyloid monoclonal antibodies for Alzheimer\u2019s disease: current landscape and future perspectives","volume":"14","author":"Kim","year":"2025","journal-title":"Transl. Neurodegen."},{"key":"10.1016\/j.cellsig.2026.112689_bb0255","doi-asserted-by":"crossref","first-page":"1575453","DOI":"10.3389\/fnins.2025.1575453","article-title":"The roles of microglia and astrocytes in neuroinflammation of Alzheimer\u2019s disease","volume":"19","author":"Han","year":"2025","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.cellsig.2026.112689_bb0260","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.jare.2025.01.007","article-title":"Calcium signaling hypothesis: a non-negligible pathogenesis in Alzheimer\u2019s disease","author":"Wang","year":"2025","journal-title":"J. Adv. Res. 77"},{"issue":"4","key":"10.1016\/j.cellsig.2026.112689_bb0265","doi-asserted-by":"crossref","first-page":"5109","DOI":"10.1007\/s12035-024-04579-6","article-title":"Alzheimer\u2019s disease-derived outer membrane vesicles exacerbate cognitive dysfunction, modulate the gut microbiome, and increase Neuroinflammation and amyloid-\u03b2 production","volume":"62","author":"Wei","year":"2025","journal-title":"Mol. Neurobiol."},{"issue":"3","key":"10.1016\/j.cellsig.2026.112689_bb0270","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1177\/13872877251350338","article-title":"Astrocytic lipidopathy and bioenergetic failure in ApoE4-associated late-onset Alzheimer\u2019s disease: a unifying hypothesis","volume":"106","author":"Garrahy","year":"2025","journal-title":"J. Alzheimer\u2019s Dis."},{"issue":"7","key":"10.1016\/j.cellsig.2026.112689_bb0275","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26073060","article-title":"Iron overload, microbleeding and the role of bilirubin in Alzheimer\u2019s disease brain: revisiting the vascular hypothesis","volume":"26","author":"Ficiar\u00e0","year":"2025","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.cellsig.2026.112689_bb0280","doi-asserted-by":"crossref","first-page":"2963","DOI":"10.1007\/s10787-025-01801-2","article-title":"Bioactive compound nanoparticles for Alzheimer\u2019s disease","volume":"33","author":"Kshirsagar","year":"2025","journal-title":"Inflammopharmacology"},{"issue":"1","key":"10.1016\/j.cellsig.2026.112689_bb0285","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1186\/s13195-024-01620-7","article-title":"Post hoc analysis of ADAMANT, a phase 2 clinical trial of active tau protein immunotherapy with AADvac1 in patients with Alzheimer\u2019s disease, positive for plasma p-tau protein217","volume":"16","author":"Kovacech","year":"2024","journal-title":"Alzheimer\u2019s Res. Ther."},{"issue":"6","key":"10.1016\/j.cellsig.2026.112689_bb0290","doi-asserted-by":"crossref","first-page":"3479","DOI":"10.1007\/s10787-025-01755-5","article-title":"Empagliflozin and memantine combination ameliorates cognitive impairment in scopolamine + heavy metal mixture-induced Alzheimer\u2019s disease in rats: role of AMPK\/mTOR, BDNF, BACE-1, neuroinflammation, and oxidative stress","volume":"33","author":"Abdel-Lah","year":"2025","journal-title":"Inflammopharmacology"},{"issue":"2","key":"10.1016\/j.cellsig.2026.112689_bb0295","first-page":"927","article-title":"Inflammatory bridges: interconnections between Alzheimer\u2019s disease and bone health","volume":"17","author":"Li","year":"2025","journal-title":"Aging Dis."},{"issue":"3","key":"10.1016\/j.cellsig.2026.112689_bb0300","doi-asserted-by":"crossref","DOI":"10.3390\/cells14030229","article-title":"Mitochondrial alterations, oxidative stress, and therapeutic implications in Alzheimer\u2019s disease: a narrative review","volume":"14","author":"Spina","year":"2025","journal-title":"Cells"},{"issue":"3","key":"10.1016\/j.cellsig.2026.112689_bb0305","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1042\/EBC20253019","article-title":"Oxidative stress - Alzheimer\u2019s disease - DNA methylation: the role of arsenic","volume":"69","author":"Antinori","year":"2025","journal-title":"Essays Biochem."},{"issue":"2","key":"10.1016\/j.cellsig.2026.112689_bb0310","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1007\/s10787-024-01636-3","article-title":"Advancements in nose-to-brain drug targeting for Alzheimer\u2019s disease: a review of nanocarriers and clinical insights","volume":"33","author":"Komal","year":"2025","journal-title":"Inflammopharmacology"},{"issue":"1","key":"10.1016\/j.cellsig.2026.112689_bb0315","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1177\/13872877251326868","article-title":"Altered tear fluid protein expression in persons with mild Alzheimer\u2019s disease in proteins involved in oxidative stress, protein synthesis, and energy metabolism","volume":"105","author":"K\u00e4rkk\u00e4inen","year":"2025","journal-title":"J. Alzheimer\u2019s Dis."},{"issue":"9","key":"10.1016\/j.cellsig.2026.112689_bb0320","doi-asserted-by":"crossref","first-page":"661","DOI":"10.2174\/0115672050366727250513061730","article-title":"Therapeutic advances in Alzheimer\u2019s disease: integrating natural, semi-synthetic, and synthetic drug strategies","volume":"22","author":"Chauhan","year":"2025","journal-title":"Curr. Alzheimer Res."},{"issue":"4","key":"10.1016\/j.cellsig.2026.112689_bb0325","doi-asserted-by":"crossref","DOI":"10.1111\/cbdd.14638","article-title":"Recent advances in medicinal chemistry of Memantine against Alzheimer\u2019s disease","volume":"104","author":"Singh","year":"2024","journal-title":"Chem. Biol. Drug Des."},{"issue":"5","key":"10.1016\/j.cellsig.2026.112689_bb0330","doi-asserted-by":"crossref","DOI":"10.1111\/cbdd.70004","article-title":"A comprehensive analysis on Galantamine based hybrids for the Management of Alzheimer\u2019s disease","volume":"104","author":"Singh","year":"2024","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.cellsig.2026.112689_bb0335","doi-asserted-by":"crossref","first-page":"1550709","DOI":"10.3389\/fneur.2025.1550709","article-title":"Reevaluating the role of amyloid \u03b2-peptides in Alzheimer\u2019s disease: from pathogenic agents to protective chelation mechanisms","volume":"16","author":"Cavaleri","year":"2025","journal-title":"Front. Neurol."},{"issue":"8","key":"10.1016\/j.cellsig.2026.112689_bb0340","doi-asserted-by":"crossref","first-page":"3449","DOI":"10.4103\/NRR.NRR-D-25-00011","article-title":"Metallothionein and neurodegenerative diseases","volume":"21","author":"Cheng","year":"2025","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.cellsig.2026.112689_bb0345","doi-asserted-by":"crossref","DOI":"10.1016\/j.ceca.2024.102928","article-title":"Targeting calciumopathy for neuroprotection: focus on calcium channels Cav1, Orai1 and P2X7","volume":"123","author":"Torres-Rico","year":"2024","journal-title":"Cell Calcium"},{"issue":"2","key":"10.1016\/j.cellsig.2026.112689_bb0350","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1039\/D4SC04453C","article-title":"Regulation of STING G-quadruplex for rescuing cellular senescence and a\u03b2 phagocytic capacity of microglia","volume":"16","author":"Yuan","year":"2025","journal-title":"Chem. Sci."},{"issue":"3","key":"10.1016\/j.cellsig.2026.112689_bb0355","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1007\/s11064-025-04460-5","article-title":"Dantrolene protects hippocampal neurons against amyloid-\u03b2\u2081\u208b\u2084\u2082-induced calcium dysregulation and cell death","volume":"50","author":"Rozumna","year":"2025","journal-title":"Neurochem. Res."},{"issue":"5","key":"10.1016\/j.cellsig.2026.112689_bb0360","doi-asserted-by":"crossref","first-page":"625","DOI":"10.2174\/011570159X379539250807114252","article-title":"Microglia-neuron interactions in Alzheimer\u2019s disease","volume":"24","author":"Ma","year":"2025","journal-title":"Curr. Neuropharmacol."},{"issue":"7","key":"10.1016\/j.cellsig.2026.112689_bb0365","doi-asserted-by":"crossref","DOI":"10.3390\/membranes15070204","article-title":"Amyloid \u03b2 1-42 can form ion channels as small as gramicidin in model lipid membranes","volume":"15","author":"Xu","year":"2025","journal-title":"Membranes"},{"issue":"7","key":"10.1016\/j.cellsig.2026.112689_bb0370","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.4103\/NRR.NRR-D-24-00398","article-title":"Acute and chronic excitotoxicity in ischemic stroke and late-onset Alzheimer\u2019s disease","volume":"20","author":"Yu","year":"2025","journal-title":"Neural Regen. Res."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112689_bb0375","doi-asserted-by":"crossref","first-page":"26248","DOI":"10.1038\/s41598-025-10795-4","article-title":"Analysis of changes in intercellular communications in Alzheimer\u2019s disease reveals conserved changes in glutamatergic transmission in mice and humans","volume":"15","author":"Bartas","year":"2025","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.cellsig.2026.112689_bb0380","doi-asserted-by":"crossref","first-page":"2977","DOI":"10.1007\/s10787-025-01765-3","article-title":"Role of mGluR7 in Alzheimer\u2019s disease: pathophysiological insights and therapeutic approaches","volume":"33","author":"Hunjan","year":"2025","journal-title":"Inflammopharmacology"},{"issue":"15","key":"10.1016\/j.cellsig.2026.112689_bb0385","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/pmic.70006","article-title":"Memantine administration enhances glutamatergic and GABAergic pathways in the human Hippocampus of Alzheimer\u2019s disease patients","volume":"25","author":"Fabrik","year":"2025","journal-title":"Proteomics"},{"issue":"6","key":"10.1016\/j.cellsig.2026.112689_bb0390","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1007\/s43440-024-00657-7","article-title":"mGlu4R, mGlu7R, and mGlu8R allosteric modulation for treating acute and chronic neurodegenerative disorders","volume":"76","author":"Domin","year":"2024","journal-title":"Pharmacol. Rep."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112689_bb0395","first-page":"1","article-title":"NR1D1 inhibition enhances autophagy and mitophagy in Alzheimer\u2019s disease models","volume":"17","author":"Zhang","year":"2025","journal-title":"Aging Dis."},{"issue":"7","key":"10.1016\/j.cellsig.2026.112689_bb0400","doi-asserted-by":"crossref","DOI":"10.1002\/alz.70099","article-title":"Interconnections of insulin\/IGF-1 signaling and autophagy abnormalities in Alzheimer\u2019s disease","volume":"21","author":"Liao","year":"2025","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.cellsig.2026.112689_bb0405","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2025.1516190","article-title":"Parishin a ameliorates cognitive decline by promoting PS1 autophagy in Alzheimer\u2019s disease","volume":"17","author":"Guo","year":"2025","journal-title":"Front. Aging Neurosci."},{"issue":"10","key":"10.1016\/j.cellsig.2026.112689_bb0410","doi-asserted-by":"crossref","first-page":"12791","DOI":"10.1007\/s12035-025-05066-2","article-title":"Chronic exercise protects against cognitive deficits in an Alzheimer\u2019s disease model by enhancing autophagy and reducing mitochondrial abnormalities","volume":"62","author":"Morais","year":"2025","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.cellsig.2026.112689_bb0415","article-title":"Berbamine targets the FKBP12-rapamycin-binding (FRB) domain of the mTOR complex to promote microglial autophagy and ameliorate neuroinflammation in Alzheimer\u2019s disease","volume":"142","author":"Ge","year":"2025","journal-title":"Phytomed. Int. J. Phytother. Phytopharm."},{"key":"10.1016\/j.cellsig.2026.112689_bb0420","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.neuroscience.2025.03.009","article-title":"Potential therapeutic targets for Alzheimer\u2019s disease: fibroblast growth factors and their regulation of ferroptosis, pyroptosis and autophagy","volume":"573","author":"Li","year":"2025","journal-title":"Neuroscience"},{"issue":"Pt 1","key":"10.1016\/j.cellsig.2026.112689_bb0425","article-title":"Adverse outcome pathway of Alzheimer\u2019s disease-like changes resulting from autophagy flux blockade after MC-LR exposure","volume":"364","author":"Ma","year":"2025","journal-title":"Environ. Pollut. (Barking, Essex\u202f: 1987)"},{"issue":"14","key":"10.1016\/j.cellsig.2026.112689_bb0430","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1093\/hmg\/ddaf097","article-title":"Expression of concern: hippocampal mutant APP and amyloid beta-induced cognitive decline, dendritic spine loss, defective autophagy, mitophagy and mitochondrial abnormalities in a mouse model of Alzheimer's disease","volume":"34","year":"2025","journal-title":"Hum. Mol. Genet."},{"issue":"5","key":"10.1016\/j.cellsig.2026.112689_bb0435","doi-asserted-by":"crossref","first-page":"6128","DOI":"10.1007\/s12035-024-04642-2","article-title":"Comparative analysis of human brain RNA-seq reveals the combined effects of Ferroptosis and autophagy on Alzheimer\u2019s disease in multiple brain regions","volume":"62","author":"Ye","year":"2025","journal-title":"Mol. Neurobiol."},{"issue":"5","key":"10.1016\/j.cellsig.2026.112689_bb0440","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1093\/brain\/awad432","article-title":"New cyclophilin D inhibitor rescues mitochondrial and cognitive function in Alzheimer\u2019s disease","volume":"147","author":"Samanta","year":"2024","journal-title":"Brain J. Neurol."},{"issue":"9","key":"10.1016\/j.cellsig.2026.112689_bb0445","doi-asserted-by":"crossref","DOI":"10.3390\/biom15091290","article-title":"Translating Alzheimer\u2019s disease mechanisms into therapeutic opportunities","volume":"15","author":"Li","year":"2025","journal-title":"Biomolecules"},{"issue":"5","key":"10.1016\/j.cellsig.2026.112689_bb0450","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26052363","article-title":"Revealing lingonberry\u2019s neuroprotective potential in Alzheimer\u2019s disease through network pharmacology and molecular docking","volume":"26","author":"Li","year":"2025","journal-title":"Int. J. Mol. Sci."},{"issue":"10","key":"10.1016\/j.cellsig.2026.112689_bb0455","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1007\/s40520-023-02482-z","article-title":"Fatigue in Alzheimer\u2019s disease: biological basis and clinical management-a narrative review","volume":"35","author":"Angioni","year":"2023","journal-title":"Aging Clin. Exp. Res."},{"issue":"9","key":"10.1016\/j.cellsig.2026.112689_bb0460","doi-asserted-by":"crossref","first-page":"2946","DOI":"10.1093\/brain\/awae156","article-title":"The vascular contribution of apolipoprotein E to Alzheimer\u2019s disease","volume":"147","author":"Chen","year":"2024","journal-title":"Brain J. Neurol."},{"issue":"2","key":"10.1016\/j.cellsig.2026.112689_bb0465","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1177\/13872877251361051","article-title":"Safety of switching from lecanemab to donanemab in 20 consecutive patients with Alzheimer\u2019s disease","volume":"107","author":"Arai","year":"2025","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"10.1016\/j.cellsig.2026.112689_bb0470","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainres.2025.149590","article-title":"Advancing Alzheimer\u2019s disease therapy through engineered exosomal macromolecules","volume":"1855","author":"Jain","year":"2025","journal-title":"Brain Res."},{"issue":"5","key":"10.1016\/j.cellsig.2026.112689_bb0475","doi-asserted-by":"crossref","DOI":"10.1111\/psyg.70097","article-title":"Dopamine system dysfunction in Alzheimer\u2019s disease","volume":"25","author":"Moreira","year":"2025","journal-title":"Psychogeriatrics"},{"issue":"Suppl. 1","key":"10.1016\/j.cellsig.2026.112689_bb0480","doi-asserted-by":"crossref","first-page":"S146","DOI":"10.1134\/S0006297924603174","article-title":"Mitochondrial genome variants and Alzheimer\u2019s disease","volume":"90","author":"Kozin","year":"2025","journal-title":"Biochemistry Biokhimiia"},{"issue":"3","key":"10.1016\/j.cellsig.2026.112689_bb0485","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/s00401-017-1738-2","article-title":"Parietal white matter lesions in Alzheimer\u2019s disease are associated with cortical neurodegenerative pathology, but not with small vessel disease","volume":"134","author":"KE","year":"2017","journal-title":"Acta Neuropathol."},{"issue":"5","key":"10.1016\/j.cellsig.2026.112689_bb0490","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/s41577-024-01104-7","article-title":"Neuroinflammation in Alzheimer disease","volume":"25","author":"Heneka","year":"2025","journal-title":"Nat. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112689_bb0495","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s13024-024-00753-5","article-title":"Multi-analyte proteomic analysis identifies blood-based neuroinflammation, cerebrovascular and synaptic biomarkers in preclinical Alzheimer\u2019s disease","volume":"19","author":"Zeng","year":"2024","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.cellsig.2026.112689_bb0500","article-title":"Single-nucleus RNA sequencing and network pharmacology reveal the mediation of fisetin on neuroinflammation in Alzheimer\u2019s disease","volume":"141","author":"Cao","year":"2025","journal-title":"Phytomed. Int. J. Phytother. Phytopharm."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112689_bb0505","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1186\/s12974-024-03277-3","article-title":"Interleukin-6 deficiency reduces neuroinflammation by inhibiting the STAT3-cGAS-STING pathway in Alzheimer\u2019s disease mice","volume":"21","author":"Liu","year":"2024","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.cellsig.2026.112689_bb0510","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2024.102548","article-title":"Inflammatory signaling pathways in Alzheimer\u2019s disease: mechanistic insights and possible therapeutic interventions","volume":"104","author":"Almutary","year":"2025","journal-title":"Ageing Res. Rev."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112689_bb0515","doi-asserted-by":"crossref","first-page":"24968","DOI":"10.1038\/s41598-025-09563-1","article-title":"Microglial exosome TREM2 ameliorates ferroptosis and neuroinflammation in alzheimer\u2019s disease by activating the Wnt\/\u03b2-catenin signaling","volume":"15","author":"Zhu","year":"2025","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112689_bb0520","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s13020-025-01098-x","article-title":"Huang-Lian-Jie-Du decoction alleviates cognitive deficits in Alzheimer\u2019s disease model 5xFAD mice by inhibiting Trem2\/Dap12 signaling pathway","volume":"20","author":"Pang","year":"2025","journal-title":"Chin. Med."},{"issue":"20","key":"10.1016\/j.cellsig.2026.112689_bb0525","doi-asserted-by":"crossref","DOI":"10.3390\/nu16203558","article-title":"Ouabain ameliorates Alzheimer\u2019s disease-associated neuropathology and cognitive impairment in FAD(4T) mice","volume":"16","author":"Wang","year":"2024","journal-title":"Nutrients"},{"issue":"1","key":"10.1016\/j.cellsig.2026.112689_bb0530","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s13024-025-00834-z","article-title":"TREM2 and sTREM2 in Alzheimer\u2019s disease: from mechanisms to therapies","volume":"20","author":"Zhang","year":"2025","journal-title":"Mol. Neurodegener."},{"issue":"8","key":"10.1016\/j.cellsig.2026.112689_bb0535","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/j.tips.2025.06.010","article-title":"TREM2 and LAG-3 in cancer and Alzheimer\u2019s disease immunotherapy","volume":"46","author":"Yuan","year":"2025","journal-title":"Trends Pharmacol. Sci."},{"issue":"11","key":"10.1016\/j.cellsig.2026.112689_bb0540","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1038\/s41580-024-00757-5","article-title":"Mechanisms of autophagy-lysosome dysfunction in neurodegenerative diseases","volume":"25","author":"Nixon","year":"2024","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"3","key":"10.1016\/j.cellsig.2026.112689_bb0545","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.7150\/ijbs.103028","article-title":"Regulatory mechanisms and therapeutic implications of lysosomal dysfunction in Alzheimer\u2019s disease","volume":"21","author":"Kim","year":"2025","journal-title":"Int. J. Biol. Sci."},{"issue":"7","key":"10.1016\/j.cellsig.2026.112689_bb0550","doi-asserted-by":"crossref","DOI":"10.1002\/alz.70486","article-title":"Loss of lysosomal acid lipase contributes to Alzheimer\u2019s disease pathology and cognitive decline","volume":"21","author":"Barnett","year":"2025","journal-title":"Alzheimers Dement."},{"issue":"6","key":"10.1016\/j.cellsig.2026.112689_bb0555","doi-asserted-by":"crossref","DOI":"10.1002\/alz.70320","article-title":"Tau protein phosphorylation at Alzheimer\u2019s disease biomarker sites impairs its cleavage by lysosomal proteases","volume":"21","author":"Lane-Donovan","year":"2025","journal-title":"Alzheimers Dement."},{"issue":"7","key":"10.1016\/j.cellsig.2026.112689_bb0560","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.tins.2025.05.007","article-title":"Amyloid precursor protein carboxy-terminal fragments as catalyzers of endolysosomal dysfunction in Alzheimer\u2019s disease","volume":"48","author":"Vrancx","year":"2025","journal-title":"Trends Neurosci."},{"issue":"19","key":"10.1016\/j.cellsig.2026.112689_bb0565","doi-asserted-by":"crossref","first-page":"7758","DOI":"10.1021\/acs.jcim.4c01344","article-title":"Network medicine approach unravels Endophenotype signature in Alzheimer\u2019s disease through large-scale comparative proteomics analysis: vascular dysfunction as a prime example","volume":"64","author":"Dai","year":"2024","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.cellsig.2026.112689_bb0570","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/bs.apcsb.2024.11.005","article-title":"Cholesterol metabolism regulates tau proteinopathy in Alzheimer\u2019s disease","volume":"147","author":"Chinnathambi","year":"2025","journal-title":"Adv. Protein Chem. Struct. Biol."},{"key":"10.1016\/j.cellsig.2026.112689_bb0575","doi-asserted-by":"crossref","first-page":"1448119","DOI":"10.3389\/fendo.2024.1448119","article-title":"Deciphering the role of lipid metabolism-related genes in Alzheimer\u2019s disease: a machine learning approach integrating traditional Chinese medicine","volume":"15","author":"Wu","year":"2024","journal-title":"Front. Endocrinol."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112689_bb0580","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s40035-024-00445-6","article-title":"TRPV1 alleviates APOE4-dependent microglial antigen presentation and T cell infiltration in Alzheimer\u2019s disease","volume":"13","author":"Lu","year":"2024","journal-title":"Transl. Neurodegen."},{"issue":"6","key":"10.1016\/j.cellsig.2026.112689_bb0585","first-page":"641","article-title":"APOE4 reprograms microglial lipid metabolism in Alzheimer\u2019s disease: mechanisms and therapeutic implications","volume":"19","author":"Chen","year":"2025","journal-title":"Biosci."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112689_bb0590","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.cell.2024.10.027","article-title":"Decreased lipidated ApoE-receptor interactions confer protection against pathogenicity of ApoE and its lipid cargoes in lysosomes","volume":"188","author":"Guo","year":"2025","journal-title":"Cell"},{"issue":"8","key":"10.1016\/j.cellsig.2026.112689_bb0595","doi-asserted-by":"crossref","DOI":"10.1016\/j.jlr.2025.100865","article-title":"Cerebrospinal fluid lipoprotein-mediated cholesterol delivery to neurons is impaired in Alzheimer\u2019s disease and involves APOE4","volume":"66","author":"Borr\u00e0s","year":"2025","journal-title":"J. Lipid Res."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112689_bb0600","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1177\/13872877241284213","article-title":"Influence of APOE4 genotype on PCSK9-lipids association in cerebrospinal fluid and serum of patients in the Alzheimer\u2019s disease continuum","volume":"102","author":"Papotti","year":"2024","journal-title":"J. Alzheimer\u2019s Dis."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112689_bb0605","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1186\/s12964-024-01832-2","article-title":"Analysis of early effects of human APOE isoforms on Alzheimer\u2019s disease and type III hyperlipoproteinemia pathways using knock-in rat models with humanized APP and APOE","volume":"22","author":"Yesiltepe","year":"2024","journal-title":"Cell Commun. Signa."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112689_bb0610","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1177\/13872877251340710","article-title":"Association of rare APOE missense variants with Alzheimer\u2019s disease in the Japanese population","volume":"106","author":"Miyashita","year":"2025","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"10.1016\/j.cellsig.2026.112689_bb0615","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2025.102713","article-title":"Mitochondrial dysfunction in Alzheimer\u2019s disease","volume":"107","author":"D\u2019Alessandro","year":"2025","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.cellsig.2026.112689_bb0620","doi-asserted-by":"crossref","first-page":"1517965","DOI":"10.3389\/fnagi.2024.1517965","article-title":"Mitochondrial dysfunction and Alzheimer\u2019s disease: pathogenesis of mitochondrial transfer","volume":"16","author":"Wei","year":"2024","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.cellsig.2026.112689_bb0625","doi-asserted-by":"crossref","first-page":"1484373","DOI":"10.3389\/fimmu.2024.1484373","article-title":"Mitochondrial dysfunction in Alzheimer\u2019s disease: a key frontier for future targeted therapies","volume":"15","author":"Wang","year":"2024","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.cellsig.2026.112689_bb0630","doi-asserted-by":"crossref","DOI":"10.1016\/j.neurot.2025.e00525","article-title":"Mitochondrial dysfunction in Alzheimer\u2019s disease: guiding the path to targeted therapies","volume":"22","author":"McGill Percy","year":"2025","journal-title":"Neurotherapeutics"},{"issue":"2","key":"10.1016\/j.cellsig.2026.112689_bb0635","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.immuni.2025.01.007","article-title":"NLRP3-mediated glutaminolysis controls microglial phagocytosis to promote Alzheimer\u2019s disease progression","volume":"58","author":"RM","year":"2025","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.cellsig.2026.112689_bb0640","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1186\/s12967-024-05680-z","article-title":"Mitochondrial dysfunction gene expression, DNA methylation, and inflammatory cytokines interaction activate Alzheimer\u2019s disease: a multi-omics Mendelian randomization study","volume":"22","author":"Zhang","year":"2024","journal-title":"J. Transl. Med."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112689_bb0645","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s40168-024-02001-w","article-title":"Akkermansia muciniphila and its metabolite propionic acid maintains neuronal mitochondrial division and autophagy homeostasis during Alzheimer\u2019s disease pathologic process via GPR41 and GPR43","volume":"13","author":"Wang","year":"2025","journal-title":"Microbiome"},{"key":"10.1016\/j.cellsig.2026.112689_bb0650","doi-asserted-by":"crossref","first-page":"1610350","DOI":"10.3389\/fnagi.2025.1610350","article-title":"Dysregulated calcium signaling in the aged primate association cortices: vulnerability to Alzheimer\u2019s disease neuropathology","volume":"17","author":"Arnsten","year":"2025","journal-title":"Front. Aging Neurosci."},{"issue":"Pt 2","key":"10.1016\/j.cellsig.2026.112689_bb0655","article-title":"Calcium dysregulation in Alzheimer\u2019s disease: unraveling the molecular nexus of neuronal dysfunction and therapeutic opportunities","volume":"242","author":"Chaudhary","year":"2025","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.cellsig.2026.112689_bb0660","article-title":"Kaixinsan regulates neuronal mitochondrial homeostasis to improve the cognitive function of Alzheimer\u2019s disease by activating CaMKK\u03b2-AMPK-PGC-1\u03b1 signaling axis","volume":"135","author":"Ren","year":"2024","journal-title":"Phytomed. Int. J. Phytother. Phytopharm."},{"key":"10.1016\/j.cellsig.2026.112689_bb0665","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2025.119567","article-title":"Isoliensinine ameliorates cognitive dysfunction in AlCl(3)\/D-gal-induced Alzheimer\u2019s disease-like mice by inhibiting the calcium signaling pathway","volume":"344","author":"Li","year":"2025","journal-title":"J. Ethnopharmacol."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112689_bb0670","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1186\/s40478-025-02023-x","article-title":"Mitochondrial dysfunction mediated by ER-calcium dysregulation in neurons derived from Alzheimer\u2019s disease patients","volume":"13","author":"Mustaly-Kalimi","year":"2025","journal-title":"Acta Neuropathol. Commun."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112689_bb0675","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.tcb.2024.08.007","article-title":"Crosstalk between mitochondria-ER contact sites and the apoptotic machinery as a novel health meter","volume":"35","author":"Larra\u00f1aga-SanMiguel","year":"2025","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.cellsig.2026.112689_bb0680","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainres.2024.149060","article-title":"Mitochondrial calcium uniporter knockdown in hippocampal neurons alleviates anxious and depressive behavior in the 3XTG Alzheimer\u2019s disease mouse model","volume":"1840","author":"Wang","year":"2024","journal-title":"Brain Res."},{"issue":"6","key":"10.1016\/j.cellsig.2026.112689_bb0685","doi-asserted-by":"crossref","first-page":"3401","DOI":"10.1007\/s11571-024-10064-6","article-title":"A\u03b2-mediated synaptic glutamate dynamics and calcium dynamics in astrocytes associated with Alzheimer\u2019s disease","volume":"18","author":"Li","year":"2024","journal-title":"Cogn. Neurodyn."},{"key":"10.1016\/j.cellsig.2026.112689_bb0690","doi-asserted-by":"crossref","first-page":"1616899","DOI":"10.3389\/fimmu.2025.1616899","article-title":"Decoding neuroinflammation in Alzheimer\u2019s disease: a multi-omics and AI-driven perspective for precision medicine","volume":"16","author":"Lin","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cellsig.2026.112689_bb0695","article-title":"A review of the current status of disease-modifying therapies and prevention of Alzheimer\u2019s disease","volume":"30","author":"Parums","year":"2024","journal-title":"Med. Sci. Monitor Int. Med. J. Exp. Clin. Res."},{"issue":"s1","key":"10.1016\/j.cellsig.2026.112689_bb0700","doi-asserted-by":"crossref","first-page":"S271","DOI":"10.3233\/JAD-240582","article-title":"Geroscience and the fight against Alzheimer\u2019s disease: between myth and reality","volume":"100","author":"Boccardi","year":"2024","journal-title":"J. Alzheimer\u2019s Dis."},{"issue":"11","key":"10.1016\/j.cellsig.2026.112689_bb0705","doi-asserted-by":"crossref","first-page":"8216","DOI":"10.1002\/alz.14184","article-title":"Recommendations for clinical implementation of blood-based biomarkers for Alzheimer\u2019s disease","volume":"20","author":"Mielke","year":"2024","journal-title":"Alzheimers Dement."},{"issue":"10","key":"10.1016\/j.cellsig.2026.112689_bb0710","doi-asserted-by":"crossref","DOI":"10.1016\/j.lanhl.2024.07.013","article-title":"Challenges in the practical implementation of blood biomarkers for Alzheimer\u2019s disease","volume":"5","author":"Sch\u00f6ll","year":"2024","journal-title":"Lancet Healthy Longev."},{"issue":"11","key":"10.1016\/j.cellsig.2026.112689_bb0715","doi-asserted-by":"crossref","first-page":"8209","DOI":"10.1002\/alz.14150","article-title":"Considerations for widespread implementation of blood-based biomarkers of Alzheimer\u2019s disease","volume":"20","author":"Mielke","year":"2024","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.cellsig.2026.112689_bb0720","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2024.105322","article-title":"Insights into the use of biomarkers in clinical trials in Alzheimer\u2019s disease","volume":"108","author":"Pascoal","year":"2024","journal-title":"EBioMedicine"},{"key":"10.1016\/j.cellsig.2026.112689_bb0725","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2024.102642","article-title":"Biomarkers of synaptic degeneration in Alzheimer\u2019s disease","volume":"104","author":"Cheng","year":"2025","journal-title":"Ageing Res. Rev."},{"issue":"2","key":"10.1016\/j.cellsig.2026.112689_bb0730","doi-asserted-by":"crossref","DOI":"10.1002\/alz.14609","article-title":"A head-to-head comparison of plasma biomarkers to detect Alzheimer\u2019s disease in a memory clinic","volume":"21","author":"Anastasi","year":"2025","journal-title":"Alzheimers Dement."},{"issue":"11","key":"10.1016\/j.cellsig.2026.112689_bb0735","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000213675","article-title":"Validating the amyloid cascade through the revised criteria of Alzheimer\u2019s Association workgroup 2024 for Alzheimer disease","volume":"104","author":"Mendes","year":"2025","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.cellsig.2026.112689_bb0740","doi-asserted-by":"crossref","DOI":"10.1002\/alz.14524","article-title":"An unsupervised learning approach for clustering joint trajectories of Alzheimer\u2019s disease biomarkers: An application to ADNI data","volume":"21","author":"S\u00f6nmez","year":"2025","journal-title":"Alzheimers Dement."},{"issue":"1_suppl","key":"10.1016\/j.cellsig.2026.112689_bb0745","first-page":"S71","article-title":"Global amyloid burden enhances network efficiency of tau protein propagation in the brain","volume":"108","author":"Lauber","year":"2024","journal-title":"J. Alzheimer\u2019s Dis"},{"issue":"12","key":"10.1016\/j.cellsig.2026.112689_bb0750","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.17219\/acem\/198674","article-title":"Anti-amyloid treatments in Alzheimer\u2019s disease: elegance, evidence and ethics","volume":"33","author":"Daly","year":"2024","journal-title":"Adv. Clin. Exp. Med."},{"issue":"11","key":"10.1016\/j.cellsig.2026.112689_bb0755","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1016\/j.ajpath.2024.10.014","article-title":"The amyloid cascade hypothesis: a conclusion in search of support","volume":"195","author":"Castellani","year":"2024","journal-title":"Am. J. Pathol."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112689_bb0760","doi-asserted-by":"crossref","DOI":"10.1002\/alz.14338","article-title":"Updated appropriate use criteria for amyloid and tau protein PET: a report from the Alzheimer\u2019s Association and Society for Nuclear Medicine and Molecular Imaging Workgroup","volume":"21","author":"Rabinovici","year":"2025","journal-title":"Alzheimers Dement."},{"issue":"4","key":"10.1016\/j.cellsig.2026.112689_bb0765","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1001\/jamaneurol.2025.0013","article-title":"Sex differences in longitudinal tau protein-PET in preclinical Alzheimer disease: a Meta-analysis","volume":"82","author":"Coughlan","year":"2025","journal-title":"JAMA Neurol."},{"issue":"9","key":"10.1016\/j.cellsig.2026.112689_bb0770","doi-asserted-by":"crossref","DOI":"10.1002\/alz.70648","article-title":"Recent advances in neuroimaging of Alzheimer\u2019s disease and related dementias","volume":"21","author":"Ottoy","year":"2025","journal-title":"Alzheimers Dement."},{"issue":"5","key":"10.1016\/j.cellsig.2026.112689_bb0775","article-title":"Explainable artificial intelligence in neuroimaging of Alzheimer\u2019s disease","volume":"15","author":"Taiyeb Khosroshahi","year":"2025","journal-title":"Diagnostics (Basel, Switzerland)"},{"issue":"7","key":"10.1016\/j.cellsig.2026.112689_bb0780","doi-asserted-by":"crossref","DOI":"10.1002\/alz.70463","article-title":"Impact of racialization on neuroimaging and plasma biomarkers of Alzheimer\u2019s disease","volume":"21","author":"Gogola","year":"2025","journal-title":"Alzheimers Dement."},{"issue":"2","key":"10.1016\/j.cellsig.2026.112689_bb0785","doi-asserted-by":"crossref","DOI":"10.1002\/alz.14600","article-title":"Machine learning prediction of tau protein-PET in Alzheimer\u2019s disease using plasma, MRI, and clinical data","volume":"21","author":"Karlsson","year":"2025","journal-title":"Alzheimers Dement."},{"issue":"15","key":"10.1016\/j.cellsig.2026.112689_bb0790","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1001\/jama.2024.13855","article-title":"Blood biomarkers to detect Alzheimer disease in primary care and secondary care","volume":"332","author":"Palmqvist","year":"2024","journal-title":"Jama"},{"issue":"10","key":"10.1016\/j.cellsig.2026.112689_bb0795","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1038\/s41562-024-01924-6","article-title":"Multiplex cerebrospinal fluid proteomics identifies biomarkers for diagnosis and prediction of Alzheimer\u2019s disease","volume":"8","author":"Guo","year":"2024","journal-title":"Nat. Hum. Behav."},{"issue":"10","key":"10.1016\/j.cellsig.2026.112689_bb0800","first-page":"1206","article-title":"Fluid biomarkers in the context of amyloid-targeting disease-modifying treatments in Alzheimer\u2019s disease","volume":"5","author":"Hu","year":"2024","journal-title":"Med (New York, NY)"},{"issue":"1","key":"10.1016\/j.cellsig.2026.112689_bb0805","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s00726-020-02928-y","article-title":"Serum amino acid profiles in patients with mild cognitive impairment and in patients with mild dementia or moderate dementia","volume":"53","author":"Socha","year":"2021","journal-title":"Amino Acids"},{"issue":"12","key":"10.1016\/j.cellsig.2026.112689_bb0810","doi-asserted-by":"crossref","DOI":"10.3390\/brainsci10120914","article-title":"Amino acid levels as potential biomarker of elderly patients with dementia","volume":"10","author":"Socha","year":"2020","journal-title":"Brain Sci."},{"issue":"6","key":"10.1016\/j.cellsig.2026.112689_bb0815","doi-asserted-by":"crossref","DOI":"10.1002\/alz.14333","article-title":"Alzheimer\u2019s Association clinical practice guideline for the diagnostic evaluation, testing, counseling, and disclosure of suspected Alzheimer\u2019s disease and related disorders (DETeCD-ADRD): executive summary of recommendations for primary care","volume":"21","author":"Atri","year":"2025","journal-title":"Alzheimers Dement."},{"issue":"2","key":"10.1016\/j.cellsig.2026.112689_bb0820","article-title":"Alzheimer\u2019s disease drug development pipeline: 2025","volume":"11","author":"Cummings","year":"2025","journal-title":"Alzheimer\u2019s & Dementia (New York, N Y)"},{"issue":"1","key":"10.1016\/j.cellsig.2026.112689_bb0825","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1038\/s41380-024-02709-z","article-title":"Alzheimer\u2019s disease biomarkers and their current use in clinical research and practice","volume":"30","author":"Hunter","year":"2025","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.cellsig.2026.112689_bb0830","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2024.123001","article-title":"Repurposing antidiabetic drugs for Alzheimer\u2019s disease: a review of preclinical and clinical evidence and overcoming challenges","volume":"355","author":"Tran","year":"2024","journal-title":"Life Sci."},{"issue":"10468","key":"10.1016\/j.cellsig.2026.112689_bb0835","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.1016\/S0140-6736(24)01883-X","article-title":"Passive anti-amyloid \u03b2 immunotherapy in Alzheimer\u2019s disease-opportunities and challenges","volume":"404","author":"Heneka","year":"2024","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.cellsig.2026.112689_bb0840","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.jconrel.2024.09.012","article-title":"Amyloid-\u03b2-targeting immunotherapies for Alzheimer\u2019s disease","volume":"375","author":"Jin","year":"2024","journal-title":"J. Control. Rel."},{"issue":"10","key":"10.1016\/j.cellsig.2026.112689_bb0845","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/S1474-4422(24)00335-1","article-title":"Brain volume change following anti-amyloid \u03b2 immunotherapy for Alzheimer\u2019s disease: amyloid-removal-related pseudo-atrophy","volume":"23","author":"Belder","year":"2024","journal-title":"Lancet Neurol."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112689_bb0850","doi-asserted-by":"crossref","DOI":"10.1002\/alz.14342","article-title":"The case for regulatory approval of amyloid-lowering immunotherapies in Alzheimer\u2019s disease based on clearcut biomarker evidence","volume":"21","author":"Aisen","year":"2025","journal-title":"Alzheimers Dement."},{"issue":"2","key":"10.1016\/j.cellsig.2026.112689_bb0855","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1159\/000545170","article-title":"Alzheimer\u2019s disease, \u03b2-amyloid peptides, and ubiquitin-proteasome system: Nutritherapeutic insights","volume":"25","author":"Simon","year":"2025","journal-title":"Neurodegener. Dis."},{"issue":"20","key":"10.1016\/j.cellsig.2026.112689_bb0860","doi-asserted-by":"crossref","DOI":"10.3390\/ijms252010964","article-title":"Pathology of amyloid-\u03b2 (a\u03b2) peptide peripheral clearance in Alzheimer\u2019s disease","volume":"25","author":"Tsoy","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"10","key":"10.1016\/j.cellsig.2026.112689_bb0865","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.it.2024.08.001","article-title":"New insights into innate immunity in Alzheimer\u2019s disease: from APOE protective variants to therapies","volume":"45","author":"Chen","year":"2024","journal-title":"Trends Immunol."},{"issue":"8","key":"10.1016\/j.cellsig.2026.112689_bb0870","doi-asserted-by":"crossref","first-page":"2590","DOI":"10.1038\/s41591-025-03835-z","article-title":"APOE \u03b54 carriers share immune-related proteomic changes across neurodegenerative diseases","volume":"31","author":"Shvetcov","year":"2025","journal-title":"Nat. Med."},{"issue":"9","key":"10.1016\/j.cellsig.2026.112689_bb0875","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuron.2025.02.017","article-title":"APOE genotype determines cell-type-specific pathological landscape of Alzheimer\u2019s disease","volume":"113","author":"Li","year":"2025","journal-title":"Neuron"},{"issue":"12","key":"10.1016\/j.cellsig.2026.112689_bb0880","doi-asserted-by":"crossref","first-page":"3113","DOI":"10.1038\/s44321-024-00162-7","article-title":"APOE from astrocytes restores Alzheimer\u2019s a\u03b2-pathology and DAM-like responses in APOE deficient microglia","volume":"16","author":"Preman","year":"2024","journal-title":"EMBO Mol. Med."},{"issue":"23","key":"10.1016\/j.cellsig.2026.112689_bb0885","doi-asserted-by":"crossref","first-page":"3877","DOI":"10.1016\/j.neuron.2024.09.006","article-title":"Alzheimer\u2019s disease-linked risk alleles elevate microglial cGAS-associated senescence and neurodegeneration in a tau proteinopathy model","volume":"112","author":"Carling","year":"2024","journal-title":"Neuron"},{"issue":"1","key":"10.1016\/j.cellsig.2026.112689_bb0890","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s00401-024-02815-w","article-title":"Hypothesis-based investigation of known AD risk variants reveals the genetic underpinnings of neuropathological lesions observed in Alzheimer\u2019s-type dementia","volume":"148","author":"Laureyssen","year":"2024","journal-title":"Acta Neuropathol."},{"issue":"11","key":"10.1016\/j.cellsig.2026.112689_bb0895","doi-asserted-by":"crossref","first-page":"7805","DOI":"10.1002\/alz.14243","article-title":"Deletion of miR-33, a regulator of the ABCA1-APOE pathway, ameliorates neuropathological phenotypes in APP\/PS1 mice","volume":"20","author":"Tate","year":"2024","journal-title":"Alzheimers Dement."},{"issue":"20","key":"10.1016\/j.cellsig.2026.112689_bb0900","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e39607","article-title":"Brain-targeting liposome-based APOE2 gene delivery exacerbates soluble amyloid-\u03b2 accumulation in app (NL-G-F) mice","volume":"10","author":"Wang","year":"2024","journal-title":"Heliyon"},{"issue":"1","key":"10.1016\/j.cellsig.2026.112689_bb0905","doi-asserted-by":"crossref","DOI":"10.1002\/alz.14397","article-title":"Plasma p-tau protein immunoassays in clinical research for Alzheimer\u2019s disease","volume":"21","author":"Teunissen","year":"2025","journal-title":"Alzheimers Dement."},{"issue":"782","key":"10.1016\/j.cellsig.2026.112689_bb0910","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adp2564","article-title":"Amyloid-associated hyperconnectivity drives tau spread across connected brain regions in Alzheimer\u2019s disease","volume":"17","author":"Roemer-Cassiano","year":"2025","journal-title":"Sci. Transl. Med."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112689_bb0915","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1080\/15548627.2024.2392408","article-title":"Mitochondrial bioenergetics stimulates autophagy for pathological MAPT\/tau protein clearance in tau proteinopathy neurons","volume":"21","author":"Jia","year":"2025","journal-title":"Autophagy"},{"issue":"2","key":"10.1016\/j.cellsig.2026.112689_bb0920","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1177\/10738584241254118","article-title":"Microglia, Trem2, and neurodegeneration","volume":"31","author":"Shi","year":"2025","journal-title":"Neuroscientist: Rev. J. Bring. Neurobiol. Neurol. Psychiatry"},{"issue":"1","key":"10.1016\/j.cellsig.2026.112689_bb0925","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1186\/s13195-024-01599-1","article-title":"Preclinical and first-in-human evaluation of AL002, a novel TREM2 agonistic antibody for Alzheimer\u2019s disease","volume":"16","author":"Long","year":"2024","journal-title":"Alzheimer\u2019s Res. Ther."},{"key":"10.1016\/j.cellsig.2026.112689_bb0930","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainresbull.2025.111280","article-title":"Treadmill exercise ameliorates hippocampal synaptic injury and recognition memory deficits by TREM2 in AD rat model","volume":"223","author":"Zhang","year":"2025","journal-title":"Brain Res. Bull."},{"issue":"4","key":"10.1016\/j.cellsig.2026.112689_bb0935","doi-asserted-by":"crossref","DOI":"10.1002\/alz.70120","article-title":"Synergistic reduction in interfacial flexibility of TREM2(R47H) and ApoE4 may underlie AD pathology","volume":"21","author":"Lietzke","year":"2025","journal-title":"Alzheimers Dement."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112689_bb0940","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s13195-025-01700-2","article-title":"TREM2 risk variants and associated endophenotypes in alzheimer\u2019s disease","volume":"17","author":"Dijkstra","year":"2025","journal-title":"Alzheimer\u2019s Res. Ther."},{"issue":"9","key":"10.1016\/j.cellsig.2026.112689_bb0945","doi-asserted-by":"crossref","first-page":"3988","DOI":"10.1038\/s41380-025-02976-4","article-title":"Higher plasma soluble TREM2 correlates with reduced cerebral tau protein accumulation in Alzheimer\u2019s disease","volume":"30","author":"Lan","year":"2025","journal-title":"Mol. Psychiatry"},{"issue":"1","key":"10.1016\/j.cellsig.2026.112689_bb0950","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13024-018-0301-5","article-title":"Early increase of CSF sTREM2 in Alzheimer\u2019s disease is associated with tau related-neurodegeneration but not with amyloid-\u03b2 pathology","volume":"14","author":"Su\u00e1rez-Calvet","year":"2019","journal-title":"Mol. Neurodegener."},{"issue":"12","key":"10.1016\/j.cellsig.2026.112689_bb0955","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1001\/jamaneurol.2021.3671","article-title":"Differences between plasma and cerebrospinal fluid glial fibrillary acidic protein levels across the Alzheimer disease continuum","volume":"78","author":"Benedet","year":"2021","journal-title":"JAMA Neurol."},{"issue":"5","key":"10.1016\/j.cellsig.2026.112689_bb0960","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.neuron.2020.09.029","article-title":"Emerging microglia biology defines novel therapeutic approaches for Alzheimer\u2019s disease","volume":"108","author":"Lewcock","year":"2020","journal-title":"Neuron"},{"issue":"21","key":"10.1016\/j.cellsig.2026.112689_bb0965","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1056\/NEJMoa010178","article-title":"Nonsteroidal antiinflammatory drugs and the risk of Alzheimer\u2019s disease","volume":"345","author":"BA","year":"2001","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112689_bb0970","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1177\/13872877251374353","article-title":"Neuroinflammation and Alzheimer\u2019s disease: unravelling the molecular mechanisms","volume":"108","author":"Kakkar","year":"2025","journal-title":"J. Alzheimer\u2019s Dis."},{"issue":"11","key":"10.1016\/j.cellsig.2026.112689_bb0975","doi-asserted-by":"crossref","DOI":"10.3390\/bios13110987","article-title":"Alzheimer\u2019s disease biomarker detection using field effect transistor-based biosensor","volume":"13","author":"Le","year":"2023","journal-title":"Biosensors"},{"issue":"13","key":"10.1016\/j.cellsig.2026.112689_bb0980","doi-asserted-by":"crossref","first-page":"3650","DOI":"10.1039\/D5BM00204D","article-title":"Engineering blood-brain barrier microphysiological systems to model Alzheimer\u2019s disease monocyte penetration and infiltration","volume":"13","author":"Gu","year":"2025","journal-title":"Biomater. Sci."},{"issue":"20","key":"10.1016\/j.cellsig.2026.112689_bb0985","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1056\/NEJMoa2304430","article-title":"Two phase 3 trials of Gantenerumab in early Alzheimer\u2019s disease","volume":"389","author":"Bateman","year":"2023","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.cellsig.2026.112689_bb0990","doi-asserted-by":"crossref","DOI":"10.1016\/j.neurot.2025.e00540","article-title":"Astrocyte and oligodendrocyte pathology in Alzheimer\u2019s disease","volume":"22","author":"Ziar","year":"2025","journal-title":"Neurotherapeutics"},{"issue":"11","key":"10.1016\/j.cellsig.2026.112689_bb0995","doi-asserted-by":"crossref","first-page":"758","DOI":"10.2174\/0115672050292472240216052614","article-title":"Alzheimer\u2019s disease and suicide: An integrative literature review","volume":"20","author":"Rodrigues","year":"2024","journal-title":"Curr. Alzheimer Res."},{"issue":"11","key":"10.1016\/j.cellsig.2026.112689_bb1000","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/S1474-4422(23)00247-8","article-title":"Stimulation of TREM2 with agonistic antibodies-an emerging therapeutic option for Alzheimer\u2019s disease","volume":"22","author":"Schlepckow","year":"2023","journal-title":"Lancet Neurol."},{"issue":"7","key":"10.1016\/j.cellsig.2026.112689_bb1005","doi-asserted-by":"crossref","DOI":"10.1111\/cns.14856","article-title":"The neuroinflammatory role of microglia in Alzheimer\u2019s disease and their associated therapeutic targets","volume":"30","author":"AmeliMojarad","year":"2024","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.cellsig.2026.112689_bb1010","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainres.2025.149573","article-title":"Comparing levetiracetam and zonisamide effects on rivastigmine anti-Alzheimer\u2019s activity in aluminum chloride-induced Alzheimer\u2019s-like disease in rats: impact on \u03b17 nicotinic acetylcholine receptors and amyloid \u03b2","volume":"1855","author":"Abdel-Aal","year":"2025","journal-title":"Brain Res."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112689_bb1015","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s11030-025-11278-4","article-title":"Design strategies, structural insights, and biological potential of amyloid-beta inhibitors in Alzheimer\u2019s disease","volume":"30","author":"Guleria","year":"2025","journal-title":"Mol. Divers."},{"issue":"19","key":"10.1016\/j.cellsig.2026.112689_bb1020","doi-asserted-by":"crossref","DOI":"10.3390\/ijms251910357","article-title":"In vivo evaluation of nose-to-brain delivery of liposomal donepezil, Memantine, and BACE-1 siRNA for Alzheimer\u2019s disease therapy","volume":"25","author":"Lee","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cellsig.2026.112689_bb1025","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.ibneur.2025.05.016","article-title":"A meta-analysis update evaluating the treatment effects of donepezil alone versus donepezil combined with memantine for Alzheimer\u2019s disease","volume":"19","author":"Hajihosseini","year":"2025","journal-title":"IBRO Neurosci. Rep."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112689_bb1030","doi-asserted-by":"crossref","DOI":"10.1172\/JCI184656","article-title":"APP lysine 612 lactylation ameliorates amyloid pathology and memory decline in Alzheimer\u2019s disease","volume":"135","author":"Tian","year":"2025","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112689_bb1035","doi-asserted-by":"crossref","first-page":"6244","DOI":"10.1038\/s41467-025-61355-3","article-title":"AI-guided patient stratification improves outcomes and efficiency in the AMARANTH Alzheimer\u2019s disease clinical trial","volume":"16","author":"Vaghari","year":"2025","journal-title":"Nat. Commun."},{"issue":"11","key":"10.1016\/j.cellsig.2026.112689_bb1040","doi-asserted-by":"crossref","first-page":"7745","DOI":"10.1002\/alz.14237","article-title":"Reversibility of cognitive worsening observed with BACE inhibitor umibecestat in the Alzheimer\u2019s prevention initiative (API) generation studies","volume":"20","author":"Tariot","year":"2024","journal-title":"Alzheimers Dement."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112689_bb1045","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/ptr.8369","article-title":"Identification of Cannabidiolic and Cannabigerolic acids as MTDL AChE, BuChE, and BACE-1 inhibitors against Alzheimer\u2019s disease by in silico, in vitro, and in vivo studies","volume":"39","author":"Vitale","year":"2025","journal-title":"Phytother. Res."},{"key":"10.1016\/j.cellsig.2026.112689_bb1050","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2024.106869","article-title":"Edaravone N-benzyl pyridinium derivatives: BACE-1 inhibition, kinetics and in silico binding pose determination","volume":"201","author":"Zondagh","year":"2024","journal-title":"Eur. J. Pharmaceut. Sci."},{"issue":"32","key":"10.1016\/j.cellsig.2026.112689_bb1055","doi-asserted-by":"crossref","first-page":"35367","DOI":"10.1021\/acsomega.5c04467","article-title":"Advances in the synthetic approaches to \u03b2-secretase (BACE-1) inhibitors in countering Alzheimer\u2019s: a comprehensive review","volume":"10","author":"Shetty","year":"2025","journal-title":"ACS Omega"},{"key":"10.1016\/j.cellsig.2026.112689_bb1060","article-title":"Developing novel Beta-secretase inhibitors in a computer model as a possible treatment for Alzheimer\u2019s disease","volume":"2025","author":"Ongtanasup","year":"2025","journal-title":"Adv. Pharm. Pharmaceut. Sci."},{"key":"10.1016\/j.cellsig.2026.112689_bb1065","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmgm.2025.109076","article-title":"Harnessing computational tools for drug discovery: An integrated computational approach to identify potential BACE-1 inhibitors","volume":"139","author":"Shareef","year":"2025","journal-title":"J. Mol. Graph. Model."},{"key":"10.1016\/j.cellsig.2026.112689_bb1070","doi-asserted-by":"crossref","first-page":"1445470","DOI":"10.3389\/fnagi.2024.1445470","article-title":"Secretase promotes AD progression: simultaneously cleave notch and APP","volume":"16","author":"Yang","year":"2024","journal-title":"Front. Aging Neurosci."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112689_bb1075","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1080\/14656566.2024.2438317","article-title":"Recent advances in Alzheimer\u2019s disease therapy: clinical trials and literature review of novel enzyme inhibitors targeting amyloid precursor protein","volume":"26","author":"Antony","year":"2025","journal-title":"Expert. Opin. Pharmacother."},{"key":"10.1016\/j.cellsig.2026.112689_bb1080","first-page":"1","article-title":"Repurposing nirogacestat, a gamma secretase enzyme inhibitor in desmoid tumors","author":"Tansir","year":"2025","journal-title":"Fut. Oncol. (London, England)"},{"issue":"4","key":"10.1016\/j.cellsig.2026.112689_bb1085","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1177\/13872877241313049","article-title":"In silico study of selected alkaloids as dual inhibitors of \u03b2- and \u03b3-secretases for Alzheimer\u2019s disease","volume":"103","author":"Onifade","year":"2025","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"10.1016\/j.cellsig.2026.112689_bb1090","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2025.118299","article-title":"Paeoniflorin exercise-mimetic potential regulates the Nrf2\/HO-1\/BDNF\/CREB and APP\/BACE-1\/NF-\u03baB\/MAPK signaling pathways to reduce cognitive impairments and neuroinflammation in amnesic mouse model","volume":"189","author":"Choi","year":"2025","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.cellsig.2026.112689_bb1095","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2025.115241","article-title":"Impaired synaptic plasticity in behaving mice by inactivation of presenilin and accumulation of the neurexin gamma-secretase proteolytic substrate","volume":"389","author":"Arias-Arag\u00f3n","year":"2025","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.cellsig.2026.112689_bb1100","article-title":"Tiaogeng decoction improves mild cognitive impairment in menopausal APP\/PS1 mice through the ERs\/NF-\u03ba b\/AQP1 signaling pathway","volume":"138","author":"Li","year":"2025","journal-title":"Phytomed. Int. J. Phytother. Phytopharm."},{"issue":"4","key":"10.1016\/j.cellsig.2026.112689_bb1105","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1177\/13872877241313031","article-title":"Iron chelation by oral deferoxamine treatment decreased brain iron and iron signaling proteins","volume":"103","author":"Thorwald","year":"2025","journal-title":"J. Alzheimer\u2019s Dis."},{"issue":"6","key":"10.1016\/j.cellsig.2026.112689_bb1110","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1212\/CON.0000000000001503","article-title":"Treatment of Alzheimer disease","volume":"30","author":"Geldmacher","year":"2024","journal-title":"Continuum (Minneapolis, Minn)"},{"issue":"2","key":"10.1016\/j.cellsig.2026.112689_bb1115","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1093\/procel\/pwae026","article-title":"Alzheimer\u2019s disease: insights into pathology, molecular mechanisms, and therapy","volume":"16","author":"Zheng","year":"2025","journal-title":"Protein Cell"},{"issue":"22","key":"10.1016\/j.cellsig.2026.112689_bb1120","doi-asserted-by":"crossref","DOI":"10.3390\/ijms252211955","article-title":"Alzheimer\u2019s disease as type 3 diabetes: understanding the link and implications","volume":"25","author":"Kciuk","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"8","key":"10.1016\/j.cellsig.2026.112689_bb1125","doi-asserted-by":"crossref","DOI":"10.1111\/jnc.70176","article-title":"Alzheimer\u2019s disease: treatment challenges for the future","volume":"169","author":"Hardy","year":"2025","journal-title":"J. Neurochem."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112689_bb1130","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/s13024-024-00776-y","article-title":"Aging-associated sensory decline and Alzheimer\u2019s disease","volume":"19","author":"Hong","year":"2024","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.cellsig.2026.112689_bb1135","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2024.102570","article-title":"Gut microbiome and Alzheimer\u2019s disease: what we know and what remains to be explored","volume":"102","author":"Kapoor","year":"2024","journal-title":"Ageing Res. Rev."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112689_bb1140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4103\/ANT.ANT_113_0046","article-title":"Gut microbiota and Alzheimer disease","volume":"34","author":"Huarcaya","year":"2025","journal-title":"Acta Neurol. Taiwanica"},{"issue":"21","key":"10.1016\/j.cellsig.2026.112689_bb1145","doi-asserted-by":"crossref","DOI":"10.3390\/ijms252111338","article-title":"Future therapeutic strategies for Alzheimer\u2019s disease: focus on behavioral and psychological symptoms","volume":"25","author":"Kwon","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"22","key":"10.1016\/j.cellsig.2026.112689_bb1150","doi-asserted-by":"crossref","DOI":"10.3390\/ijms252212311","article-title":"From fundamentals to innovation in Alzheimer\u2019s disease: molecular findings and revolutionary therapies","volume":"25","author":"Sighencea","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112689_bb1155","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1177\/13872877241283677","article-title":"Involvement of inflammasomes in the pathogenesis of Alzheimer\u2019s disease","volume":"102","author":"Beder","year":"2024","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"10.1016\/j.cellsig.2026.112689_bb1160","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2024.102593","article-title":"The new perspective of Alzheimer\u2019s disease research: mechanism and therapeutic strategy of neuronal senescence","volume":"102","author":"Niu","year":"2024","journal-title":"Ageing Res. Rev."},{"issue":"22","key":"10.1016\/j.cellsig.2026.112689_bb1165","doi-asserted-by":"crossref","DOI":"10.3390\/ijms252211873","article-title":"Mechanism of metal complexes in Alzheimer\u2019s disease","volume":"25","author":"Liu","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"12","key":"10.1016\/j.cellsig.2026.112689_bb1170","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1016\/j.molmed.2024.10.010","article-title":"Advancements and challenges in mouse models of Alzheimer\u2019s disease","volume":"30","author":"Qian","year":"2024","journal-title":"Trends Mol. Med."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112689_bb1175","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1186\/s13195-024-01578-6","article-title":"Multi-omics analysis reveals the key factors involved in the severity of the Alzheimer\u2019s disease","volume":"16","author":"Meng","year":"2024","journal-title":"Alzheimer\u2019s Res. Ther."},{"issue":"5","key":"10.1016\/j.cellsig.2026.112689_bb1180","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.neurol.2025.03.005","article-title":"Epilepsy and Alzheimer disease: new insights and perspectives","volume":"181","author":"Dupont","year":"2025","journal-title":"Rev. Neurol."},{"issue":"4","key":"10.1016\/j.cellsig.2026.112689_bb1185","doi-asserted-by":"crossref","DOI":"10.3390\/cells14040264","article-title":"Immune modulation in Alzheimer\u2019s disease: from pathogenesis to immunotherapy","volume":"14","author":"Balkhi","year":"2025","journal-title":"Cells"},{"issue":"7","key":"10.1016\/j.cellsig.2026.112689_bb1190","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26073015","article-title":"The impact of the Exposome on Alzheimer\u2019s disease: the influence of nutrition","volume":"26","author":"Monaco","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cellsig.2026.112689_bb1195","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2025.102711","article-title":"Cognitive resilience in Alzheimer\u2019s disease: mechanism and potential clinical intervention","volume":"106","author":"Jia","year":"2025","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.cellsig.2026.112689_bb1200","doi-asserted-by":"crossref","first-page":"1583886","DOI":"10.3389\/fimmu.2025.1583886","article-title":"NLRP3 inflammasome in Alzheimer\u2019s disease: molecular mechanisms and emerging therapies","volume":"16","author":"Li","year":"2025","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112689_bb1205","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1186\/s13195-024-01607-4","article-title":"Exploring easily accessible neurophysiological biomarkers for predicting Alzheimer\u2019s disease progression: a systematic review","volume":"16","author":"Costanzo","year":"2024","journal-title":"Alzheimer\u2019s Res. Ther."},{"key":"10.1016\/j.cellsig.2026.112689_bb1210","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2025.105557","article-title":"Synapse vulnerability and resilience underlying Alzheimer\u2019s disease","volume":"112","author":"Taddei","year":"2025","journal-title":"EBioMedicine"},{"key":"10.1016\/j.cellsig.2026.112689_bb1215","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.freeradbiomed.2024.09.051","article-title":"Free radicals in Alzheimer\u2019s disease: from pathophysiology to clinical trial results","volume":"225","author":"Vi\u00f1a","year":"2024","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.cellsig.2026.112689_bb1220","doi-asserted-by":"crossref","first-page":"5550938","DOI":"10.1155\/2021\/5550938","article-title":"The potential benefits of nanotechnology in treating Alzheimer\u2019s disease","volume":"2021","author":"Ling","year":"2021","journal-title":"Biomed. Res. Int."},{"issue":"3","key":"10.1016\/j.cellsig.2026.112689_bb1225","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/S1474-4422(25)00425-9","article-title":"Epileptic activity in Alzheimer\u2019s disease: emerging insights and therapeutic implications","volume":"25","author":"Vossel","year":"2026","journal-title":"Lancet Neurol."}],"container-title":["Cellular Signalling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S089865682600344X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S089865682600344X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T11:28:30Z","timestamp":1785151710000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S089865682600344X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":245,"alternative-id":["S089865682600344X"],"URL":"https:\/\/doi.org\/10.1016\/j.cellsig.2026.112689","relation":{},"ISSN":["0898-6568"],"issn-type":[{"value":"0898-6568","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neuroinflammation-centered pathophysiology and therapeutic strategy design in Alzheimer's disease: Cutting-edge developments","name":"articletitle","label":"Article Title"},{"value":"Cellular Signalling","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cellsig.2026.112689","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"112689"}}